Analysis and Commentary 9/25/20 Analysis and Commentary 9/25/20 How FDA is Funded, ... and Why Read More Analysis and Commentary 3/22/19 Analysis and Commentary 3/22/19 Sorting Out the Details of the President's FY 20 Request Read More 1/11/19 1/11/19 The Shutdown Continues: More Qs; More As Read More Analysis and Commentary 9/8/17 Analysis and Commentary 9/8/17 Some Shocks -- Some Pleasant; Some Less So Read More Analysis and Commentary 3/24/17 Analysis and Commentary 3/24/17 Ag/FDA Appropriations Subcommittees Need to Hear From Entire Stakeholder Community Read More Advocacy at a Glance 3/24/17 Advocacy at a Glance 3/24/17 President’s Budget Blueprint Puts FDA at Risk and more Read More Analysis and Commentary 2/5/16 Analysis and Commentary 2/5/16 Hunting for the Wheat in the Chaff of Hyperbole Read More
Analysis and Commentary 9/25/20 Analysis and Commentary 9/25/20 How FDA is Funded, ... and Why Read More
Analysis and Commentary 3/22/19 Analysis and Commentary 3/22/19 Sorting Out the Details of the President's FY 20 Request Read More
Analysis and Commentary 9/8/17 Analysis and Commentary 9/8/17 Some Shocks -- Some Pleasant; Some Less So Read More
Analysis and Commentary 3/24/17 Analysis and Commentary 3/24/17 Ag/FDA Appropriations Subcommittees Need to Hear From Entire Stakeholder Community Read More
Advocacy at a Glance 3/24/17 Advocacy at a Glance 3/24/17 President’s Budget Blueprint Puts FDA at Risk and more Read More
Analysis and Commentary 2/5/16 Analysis and Commentary 2/5/16 Hunting for the Wheat in the Chaff of Hyperbole Read More
